Biology and Therapeutic Application of Mesenchymal Cells (eBook)
1048 Seiten
Wiley (Verlag)
978-1-118-90729-0 (ISBN)
The Biology and Therapeutic Application of Mesenchymal Cells comprehensively describes the cellular and molecular biology of mesenchymal stem cells and mesenchymal stromal cells, describing their therapeutic potential in a wide variety of preclinical models of human diseases and their mechanism of action in these preclinical models. Chapters also discuss the current status of the use of mesenchymal stem and stromal cells in clinical trials in a wide range of human diseases and disorders, for many of which there are limited, or no other, therapeutic avenues.
- Provides coverage on both the biology of mesenchymal stem cells and stromal cells, and their therapeutic applications
- Describes the therapeutic potential of mesenchymal stem and stromal cells in a wide variety of preclinical models of human diseases and their mechanism of action in these preclinical models
- Discusses the current status of mesenchymal stem and stromal cells in clinical trials in a wide range of human diseases and disorders, for many of which there are limited, or no other, therapeutic avenues
- Written and edited by leaders in the field
The Biology and Therapeutic Application of Mesenchymal Cells is an invaluable resource for those studying stem cells, cell biology, genetics, gene or cell therapy, or regenerative medicine.
Kerry Atkinson, MBBS MD DTM&H FRCP FRACP, is an Adjunct Professor at the University of Queensland Centre for Clinical Research in Brisbane, Australia, an Adjunct Professor in the Stem Cell Laboratories, Queensland University of Technology at the Translational Research Institute, Brisbane, Queensland, Australia and a Specialist in Internal Medicine at the Salisbury Medical Centre, Brisbane, Queensland, Australia.
The Biology and Therapeutic Application of Mesenchymal Cells comprehensively describes the cellular and molecular biology of mesenchymal stem cells and mesenchymal stromal cells, describing their therapeutic potential in a wide variety of preclinical models of human diseases and their mechanism of action in these preclinical models. Chapters also discuss the current status of the use of mesenchymal stem and stromal cells in clinical trials in a wide range of human diseases and disorders, for many of which there are limited, or no other, therapeutic avenues. Provides coverage on both the biology of mesenchymal stem cells and stromal cells, and their therapeutic applications Describes the therapeutic potential of mesenchymal stem and stromal cells in a wide variety of preclinical models of human diseases and their mechanism of action in these preclinical models Discusses the current status of mesenchymal stem and stromal cells in clinical trials in a wide range of human diseases and disorders, for many of which there are limited, or no other, therapeutic avenues Written and edited by leaders in the field The Biology and Therapeutic Application of Mesenchymal Cells is an invaluable resource for those studying stem cells, cell biology, genetics, gene or cell therapy, or regenerative medicine.
Contributors
Anurag Agrawal, Centre of Excellence for Translational Research in Asthma & Lung Disease, CSIR-Institute of Genomics and Integrative Biology, Delhi, India
Tanveer Ahmad, Centre of Excellence for Translational Research in Asthma & Lung Disease, CSIR-Institute of Genomics and Integrative Biology, Delhi, India
Giulio Alessandri, Department of Cerebrovascular Diseases, Fondazione IRCCS Neurological Institute Carlo Besta, Milan, Italy
Chullikana Anoop, Stempeutics Research Pvt Ltd, Whitefield, Bangalore, India
Jesse D. Armitage, Centre for Asthma, Allergy and Respiratory Research, School of Medicine & Pharmacology; Stem Cell Unit, Institute of Respiratory Health; University of Western Australia, Nedlands, WA, Australia
Kerry Atkinson, The University of Queensland Centre for Clinical Research, Brisbane, Queensland, Australia; The Queensland University of Technology/Institute of Health and Biomedical Innovation at the Translational Research Centre, Brisbane, Queensland, Australia; Salisbury Medical Centre, Brisbane, Australia
Luigi Balducci, Medestea Research and Production Laboratories, Consorzio CARSO, Bari, Italy
Wayne Balkan, The Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL, USA
Jennifer J. Bara, AO Research Institute Davos, Davos Platz, Switzerland
Frédéric Baron, Department of Hematology, Le Centre Hospitalier Universitaire of Liège and Unit of Hematology, University of Liège, Liège, Belgium
Frank Barry, Regenerative Medicine Institute, National University of Ireland Galway, Galway, Ireland
Etienne Baudoux, Laboratory of Cell and Gene Therapy (LTCG), Le Centre Hospitalier Universitaire of Liège and University of Liège, Liège, Belgium
Julie R. Beegle, The Institute for Regenerative Cures/Stem Cell Program, University of California, Davis, Sacramento, CA, USA
Yves Beguin, Department of Hematology; Laboratory of Cell and Gene Therapy (LTCG), Le Centre Hospitalier Universitaire of Liège and Unit of Hematology, University of Liège, Liège, Belgium
Y.A. Belyi, S.N. Fyodorov Eye Microsurgery Complex Kaluga Affiliate, Kaluga, Russia
Naveen K. Bhatraju, Centre of Excellence for Translational Research in Asthma & Lung Disease, CSIR-Institute of Genomics and Integrative Biology, Delhi, India
Francisco J. Blanco, Proteomics Group-ProteoRed-PRB2/ISCIII, Rheumatology Division INIBIC-CHU A Coruña, Spain
Josephine Bodle, Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, NC, USA
Siddaraju V. Boregowda, Department of Molecular Therapeutics, The Scripps Research Institute, Scripps Florida, Jupiter, FL, USA
Laura J. Bray, School of Biomedical Sciences, Institute of Health & Biomedical Innovation, Queensland University of Technology, Brisbane, Australia; Queensland Eye Institute, South Brisbane, Australia; Leibniz Institute for Polymer Research Dresden, Max Bergmann Center of Biomaterials, Dresden, Germany
Jan E. Brinchmann, Norwegian Center for Stem Cell Research, Department of Immunology, Oslo University Hospital and University of Oslo, Oslo, Norway
Alexandra Briquet, Laboratory of Cell and Gene Therapy (LTCG), Le Centre Hospitalier Universitaire of Liège and University of Liège, Liège, Belgium
Annelies Bronckaers, Group of Morphology, Biomedical Research Institute (BIOMED), Hasselt University, Diepenbeek, Belgium
Gary Brooke, Reneuron, Guildford, Surrey, UK
Dimitrios Cakouros, Mesenchymal Stem Cell Laboratory, School of Medical Sciences, Faculty of Health Sciences, University of Adelaide, South Australia, Australia; Cancer Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia
Irene Calvo-Asensio, Biosciences, Newcastle Road, Dangan, National University of Ireland, Galway, Ireland
Rhodri Ceredig, Biosciences, Newcastle Road, Dangan, National University of Ireland, Galway, Ireland
Adisri Charoenpanich, Biology Department, Faculty of Science, Silpakorn University, Thailand
Lin Chen, Department of Oral and Maxillofacial Surgery, The Second Xiangya Hospital, Central South University, Changsha, Peoples Republic of China
Qing Chen, Key Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences/Shanghai Jiao Tong University School of Medicine, Shanghai, China
James A. Cornwell, Developmental and Stromal Cell Biology Division, Victor Chang Cardiac Research Institute; Graduate School of Biomedical Engineering, University of New South Wales, Sydney, NSW, Australia
Sharon Natasha Cox, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy
A.T. Crane, Field Neurosciences Institute Laboratory for Restorative Neurology, Brain Research and Integrative Neuroscience Center, Program in Neuroscience, Central Michigan University, Mount Pleasant, MI
Brendan G. Cronin, Queensland Eye Institute, South Brisbane, Australia
Olivier Delloye, Laboratory of Cell and Gene Therapy (LTCG), Le Centre Hospitalier Universitaire of Liège and University of Liège, Liège, Belgium
Olivier Detry, Department of Abdominal Surgery and Transplantation, CHU of Liège and University of Liège, Liège, Belgium
Michael Doran, Queensland University of Technology/Institute of Health and Biomedical Innovation at the Translational Research Institute, Brisbane, Queensland, Australia
G.L. Dunbar, Field Neurosciences Institute Laboratory for Restorative Neurology, Brain Research and Integrative Neuroscience Center, Program in Neuroscience, Central Michigan University, Mount Pleasant, MI, USA; Field Neurosciences Institute, Saginaw, MI, USA
K. Jane Escott, Emerging Innovations Unit, Scientific Partnering and Alliances, AstraZeneca R&D, Cheshire, UK
Leah Etheridge, Department of Biology, University of York, York, UK
Fernando A. Fierro, The Institute for Regenerative Cures/Stem Cell Program, University of California, Davis, Sacramento, CA, USA
Leanne Foyn, School of Biomedical Sciences, Queensland University of Technology, Brisbane, Australia; Queensland Eye Institute, South Brisbane, Australia
Jacques Galipeau, Department of Hematology and Medical Oncology, Winship Cancer Institute, Atlanta, GA, USA
Caroline E. Gargett, Department of Obstetrics and Gynaecology, Monash University, Victoria, Australia; MIMR-PHI Institute of Medical Research, Clayton, Victoria, Australia
Tatyana Gavrilova, Albert Einstein College of Medicine and The Montefiore Medical Center, New York, NY, USA
Sean Gaynard, Regenerative Medicine Institute, National University of Ireland Galway, Galway, Ireland
Paul Genever, Department of Biology, University of York, York, UK
Sailaja Ghanta, Pediatric Newborn Medicine, Brigham and Women's Hospital, Boston, MA, USA
Olivier Giet, Laboratory of Cell and Gene Therapy (LTCG), Le Centre Hospitalier Universitaire of Liège and University of Liège, Liège, Belgium
Stuart B. Goodman, Department of Orthopedic Surgery, Stanford University, Stanford, CA, USA
Céline Gregoire, Department of Hematology, Le Centre Hospitalier Universitaire of Liège and Unit of Hematology, University of Liège, Liège, Belgium
Stan Gronthos, Mesenchymal Stem Cell Laboratory, School of Medical Sciences, Faculty of Health Sciences, University of Adelaide, South Australia, Australia; Cancer Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia
Varun Gudapati, University of California San Francisco, Department of Anesthesiology, San Francisco, CA, USA
P.K. Gupta, Stempeutics Research Pvt Ltd, Whitefield, Bangalore, India
Shanti Gurung, Department of Obstetrics and Gynaecology, Monash University, Victoria, Australia; MIMR-PHI Institute of Medical Research, Clayton, Victoria, Australia
Maria Z. Gutierrez, Graduate School of Biomedical Engineering, University of New South Wales, Sydney, Australia
Joshua Hare, The Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL, USA
Damien G. Harkin, School of Biomedical Sciences, Institute of Health & Biomedical Innovation, Queensland University of Technology, Brisbane, Australia; Queensland Eye Institute, South Brisbane, Australia
Richard P. Harvey, Developmental and Stromal Cell Biology Division, Victor Chang Cardiac Research Institute, Sydney, NSW, Australia; St Vincent's Clinical School and School of Biotechnology, Biomolecular Sciences, University of New South Wales, Kensington, Sydney, Australia
Jessica Hayes, Regenerative Medicine Institute, National University of Ireland Galway, Galway, Ireland
Celena F. Heazlewood, University of Queensland Centre for Clinical Research, Brisbane, Australia
Sarah Elizabeth Hemming, Mesenchymal Stem Cell Laboratory, School of Medical Sciences, Faculty of Health Sciences, University of Adelaide, South...
Erscheint lt. Verlag | 8.11.2016 |
---|---|
Sprache | englisch |
Themenwelt | Studium ► 1. Studienabschnitt (Vorklinik) ► Physiologie |
Naturwissenschaften ► Biologie ► Zellbiologie | |
Technik | |
ISBN-10 | 1-118-90729-9 / 1118907299 |
ISBN-13 | 978-1-118-90729-0 / 9781118907290 |
Haben Sie eine Frage zum Produkt? |
Größe: 55,4 MB
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belletristik und Sachbüchern. Der Fließtext wird dynamisch an die Display- und Schriftgröße angepasst. Auch für mobile Lesegeräte ist EPUB daher gut geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich